Christopher J Schaepe Net Worth
The estimated Net Worth of Christopher J Schaepe is at least $8.25 Million dollars as of 16 August 2018. Christopher Schaepe owns over 66,542 units of Forty Seven stock worth over $502,392 and over the last 12 years Christopher sold FTSV stock worth over $7,745,658.
Christopher Schaepe FTSV stock SEC Form 4 insider trading
Christopher has made over 10 trades of the Forty Seven stock since 2017, according to the Form 4 filled with the SEC. Most recently Christopher sold 10,192 units of FTSV stock worth $35,264 on 12 December 2018.
The largest trade Christopher’s ever made was buying 597,858 units of Forty Seven stock on 6 July 2017 worth over $4,185,006. On average, Christopher trades about 30,867 units every 12 days since 2007. As of 16 August 2018 Christopher still owns at least 66,542 units of Forty Seven stock.
You can see the complete history of Christopher Schaepe stock trades at the bottom of the page.
What’s Christopher Schaepe’s mailing address?
Christopher’s mailing address filed with the SEC is 2200 Sand Hill Rd, Menlo Park, CA 94025, USA.
Insider trading at Forty Seven
Over the last few years, insiders at Forty Seven have traded over $4,118,522 worth of Forty Seven stock and bought 2,621,245 units worth $41,666,515 . The most active insider traders include Tench Coxe, Michael L Speiser, and Jeffrey W Bird. On average, Forty Seven executives and independent directors trade stock every 7 days with the average trade being worth of $569,591. The most recent stock trade was executed by Mark Anthony Mc Camish on 20 May 2019, trading 16,500 units of FTSV stock currently worth $80,520.
What does Forty Seven do?
Forty Seven, Inc. develops therapies that target cancer immune evasion pathways. It develops Hu5F9-G4, a monoclonal antibody against human CD47 that potentially has applications spanning multiple tumor types and treatment modalities. The company was founded by Irving L. Weissman, Ravi Majeti, Mark Chao and Jens-Peter Volkmer in 2014 and is headquartered in Menlo Park, CA.
What does Forty Seven’s logo look like?
Complete history of Christopher Schaepe stock trades at eHealth, Nutanix, Stitch Fix, and Forty Seven
Forty Seven executives and stock owners
Forty Seven executives and other stock owners filed with the SEC include:
- Mark McCamish, President, Chief Executive Officer, Director
- Ann Rhoads, Chief Financial Officer
- Chris Takimoto, Chief Medical Officer
- Ian Clark, Independent Director
- Craig Gibbs, Chief Business Officer
- Kristine Ball, Independent Director
- Jeffrey Bird, Lead Independent Director
- Dennis Henner, Independent Director
- Ravindra Majeti, Independent Director
- Irving Weissman, Independent Director
- Samuel J Iii Pullara,
- Harbor Master Investors (Ca…, 10% owner
- Michael L Speiser, 10% owner
- Stefan A Dyckerhoff,
- Venture Partners X, L.P.Lig…,
- Hill Ventures Sutter,
- Peter Nieh, 10% owner
- Christopher J Schaepe, Director
- Tench Coxe, 10% owner
- Dennis Henner, Director
- James N White, 10% owner
- Venture Partners Select Ii,…,
- Ravi Mhatre, 10% owner